Citation: Gross L (2006) Iron Regulation and an Opportunistic AIDS-Related Fungal Infection. PLoS Biol 4(12): e427. https://doi.org/10.1371/journal.pbio.0040427
Published: November 21, 2006
Copyright: © 2006 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Because HIV attacks the very cells charged with fighting infection, the virus compromises the body’s ability to co-exist with pathogens that are otherwise harmless. It is these pathogen-induced opportunistic infections, and not the virus itself, that produce the most debilitating effects of the disease. The appearance of specific opportunistic infections—including the life-threatening fungal infection cryptococcosis—signals progression to AIDS. Nearly all AIDS-related cryptococcosis cases worldwide are caused by Cryptococcus neoformans, a single-celled fungus originally isolated over 100 years ago.
A critical factor in C. neoformans infection is iron availability. Because iron also supports fundamental host cell processes, the pathogen must compete with the host to secure enough iron for survival and replication. Genetic and nutritional factors, along with HIV itself, promote iron accumulation in cells and organs, dramatically increasing its availability to C. neoformans and other potential pathogens. Understanding how pathogenic fungi sense host resources and control virulence-related factors is essential for developing effective antifungal therapies. In a new study, Won Hee Jung, James Kronstad, and colleagues identify a gene in C. neoformans that coordinates both processes, revealing a potentially powerful antifungal strategy. The gene, called Cryptococcus iron regulator (CIR1), regulates not only the pathogen’s response to iron but also its ability to establish virulent infection.
Studies in other fungi, including a harmless laboratory yeast, showed that cell-surface enzymes called reductases facilitate iron uptake by reducing extracellular iron (that is, transforming it into a biologically available state through electron transfer). Such studies also identified three transcription factors involved in maintaining the proper balance, or homeostasis, of cellular iron by repressing the components of the iron-uptake pathway. Using the sequences of these transcription-repressing iron regulators, the authors identified CIR1 as a candidate regulator in C. neoformans. Like the other regulators, the gene contains a region rich in cysteine bases and a “zinc finger motif,” which in the other regulators binds to the promoters of iron transporter genes.
To investigate CIR1’s function, the authors deleted its coding sequences from two C. neoformans strains. Loss of a transcriptional repressor in the laboratory yeast leads to increased cell-surface reductase activity (which is evident when a colorless indicator dye in the growth medium turns red from the enzyme’s reducing activity). In contrast to the nonmutant, or wild-type, cells, cir1 mutants appeared reddish. But when the authors added the CIR1 gene to the mutant cells, they looked the same as the wild-type cells, indicating that the loss of CIR1 led to increased reductase activity. Mutants also showed signs of sensitivity to excess iron, revealing CIR1’s role in iron homeostasis.
To establish virulent infection, C. neoformans must be able to grow at 37 °C, deposit melanin in the cell wall, and produce a polysaccharide capsule (displayed in the image).
To examine how the mutation changed the transcription of iron-related genes, the authors grew mutant and wild-type strains in high and low iron concentrations and then analyzed their gene-expression profiles with microarrays. The profiles of mutant and wild-type strains showed “substantial” differences in both iron backgrounds, indicating that the Cir1 protein senses iron levels and coordinates gene expression accordingly. Genes involved in iron transport were most affected by iron availability and CIR1 deletion. Based on the microarrays, the authors concluded that Cir1 represses iron uptake mediated by reductases but activates uptake mediated by transport molecules called siderophores. The arrays also revealed that the gene influences melanin production, an important virulence factor that thwarts host antimicrobial proteins.
The authors explored the cir1 mutation’s effects on C. neoformans virulence in the wild-type and mutant strains and found that capsule formation—which disrupts the host’s cellular defenses—was absent in mutant cells. This defect appears to arise in part because the mutation inhibits signaling pathways required for capsule formation. The mutants also showed substantial defects in an absolutely critical virulence factor: the capacity to grow at host body temperature (37 °C). The authors confirmed that CIR1 exerts significant control over C. neoformans virulence in experiments with mice. Mice exposed to a normally virulent strain lacking CIR1 showed no serious symptoms, while mice infected with strains containing the protein died within 20 days.
Altogether, these findings demonstrate that CIR1 controls the expression of genes required for C. neoformans virulence—and that iron regulation plays a critical role in cryptococcal infection. This intimate connection between iron and virulence suggests that targeting CIR1 or otherwise disrupting iron regulation might prove an effective strategy for controlling one of the most common life-threatening fungal infections in persons with AIDS.